In an otherwise healthy adult female undergoing standard breast augmentation, how should PECS I and PECS II blocks be incorporated—including optimal anatomical planes, added procedural time, and appropriate patient billing—and are they essential for successful outcomes?

PECS Blocks in Breast Augmentation: Not Essential but Beneficial

PECS I and II blocks are not essential for successful breast augmentation outcomes, but when incorporated, they provide superior early postoperative pain control (first 6-24 hours) compared to local infiltration alone, reducing opioid consumption and improving patient satisfaction. 1, 2, 3

Evidence-Based Context

The available evidence comes primarily from oncological breast surgery guidelines 4, which recommend PECS blocks as an alternative to paravertebral blocks for major breast surgery. However, breast augmentation is fundamentally different—it's elective cosmetic surgery in healthy patients with lower baseline pain than oncological procedures. The most recent aesthetic surgery data 1, 2 demonstrates clear benefits but confirms augmentations "do well without it."

Technical Incorporation

Anatomical Planes

• PECS I: Inject local anesthetic between pectoralis major and minor muscles 4
• PECS II: Add injection between pectoralis minor and serratus anterior muscles 4
• Perform under ultrasound guidance preoperatively 1, 2
• Typical dosing: 10 mL of 0.5% bupivacaine for PECS I, 20 mL for PECS II 3

Time Added

• 5-10 minutes per side for bilateral blocks 1, 2
• Requires anesthesiologist proficiency with ultrasound-guided techniques
• Performed after induction, before surgical incision

Clinical Outcomes: What the Data Shows

Pain Control Timeline

The 2026 split-body study 2 provides the clearest evidence:

• 0-6 hours: PECS I significantly superior to local infiltration (p < 0.05)
• 24 hours: No difference between techniques
• Day 5 and 3 months: No difference

The 2026 opioid-free series 1 showed:

• Mean VAS < 2 by 72 hours across all implant planes
• Pain peaks at 16 hours regardless of technique
• No patients required rescue opioids in 627 cases

Opioid Reduction

• 24-hour fentanyl consumption reduced by 70% (378.7 μg vs 115.7 μg) 3
• 93.3% of studies show reduced 24-hour postoperative opioid use 5

Secondary Benefits

• Lower nausea/vomiting rates (2/27 vs 9/27 patients) 3
• Shorter hospital stay (24.4 vs 27.0 hours) 3
• Earlier return to normal activities (within 4 days) 1

Critical Limitations

Important caveat: The oncological guidelines 4 note that PECS blocks cannot reliably provide analgesia to the axilla (T1 distribution) 4. For augmentation, this is less relevant since axillary dissection isn't performed, but supplemental local infiltration may still be beneficial.

PECS I alone showed no reduction in pain scores when added to multimodal analgesia in one study 4, though subgroups undergoing major surgery did benefit. This suggests PECS II may be more effective than PECS I alone.

Billing Considerations

The evidence does not address specific billing codes or charges. However:

• Requires anesthesiologist time and ultrasound equipment
• Adds procedural complexity and documentation requirements
• Cost-effectiveness studies in oncological surgery showed higher upfront costs offset by reduced hospital stay 4
• For outpatient cosmetic surgery, consider: anesthesiologist fee, ultrasound use, additional monitoring time

Practical approach: Charge should reflect anesthesiologist time (10-15 minutes), equipment use, and documented improved outcomes. Market rates vary regionally; consider bundling into enhanced recovery protocols rather than itemizing separately.

When to Incorporate PECS Blocks

Strong Indications:

• Dual-plane or submuscular placement (highest pain burden) 1
• Patients with high anxiety about postoperative pain
• Desire for opioid-free or opioid-minimizing protocols
• Larger implant volumes (weak correlation but present, ρ = 0.20) 1

Less Critical:

• Pre-pectoral placement (lowest pain burden) 1
• Patients tolerant of standard multimodal analgesia
• When anesthesiologist expertise unavailable

Alternative Approach:

If PECS blocks unavailable, direct local anesthetic infiltration (10 mL 0.5% bupivacaine per side) provides adequate analgesia after the first 6 hours 2. Combine with:

• Preoperative paracetamol and NSAIDs 4
• Intraoperative dexamethasone 4
• Postoperative scheduled NSAIDs, not just PRN opioids

Algorithm for Decision-Making

1. Assess implant plane: Dual-plane/submuscular → stronger consideration for PECS
2. Evaluate anesthesia resources: Ultrasound-trained anesthesiologist available?
3. Patient preference: Discuss opioid-minimizing vs. standard approach
4. If proceeding with PECS: Perform PECS II (not just PECS I) for optimal coverage
5. Always include basic multimodal analgesia regardless of block choice

Bottom Line

Breast augmentations achieve excellent outcomes without PECS blocks when standard multimodal analgesia is used. The blocks provide meaningful but time-limited improvement in early postoperative pain (first 6 hours) and reduce opioid consumption. Incorporate them when resources permit and patient/surgical factors favor enhanced analgesia, but they are not mandatory for success. The 2026 data 1 demonstrating zero rescue opioid use in 627 patients represents the strongest evidence for their efficacy in aesthetic breast surgery specifically, though this was in the context of a comprehensive protocol.